Related Experiment Videos
[Endogenous dopamine modulates cortico-pallidal influence via GABA]
V V Raevskiĭ1, G S Dawe, J D Stevenson
1Institute of Higher Nervous Activity and Neurophysiology of the Russian Acad. Sci., Russia, 117485, Moscow, Butlerov St., 5a.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova
|August 6, 2002
Summary
Dopamine receptor antagonists modulate globus pallidus neuronal activity. Blocking D1 receptors (SCH 23390) inhibits short-latency responses, while blocking D2 receptors (raclopride) reveals long-latency responses, suggesting dopamine
Area of Science:
- Neuroscience
- Neuropharmacology
- Basal Ganglia Function
Context:
- Investigates the role of dopamine receptors in modulating neuronal activity within the globus pallidus.
- Examines the effects of specific D1 and D2 receptor antagonists on neural pathways originating from the somatosensory cortex.
- Utilizes Sprague-Dawley rats as a model system for studying basal ganglia circuitry.
Purpose:
- To elucidate the distinct roles of D1 and D2 dopamine receptors in shaping globus pallidus neuronal responses to cortical stimulation.
- To determine how blocking D1 and D2 receptors influences short- and long-latency inhibitory signals.
- To explore the underlying mechanisms involving GABAergic neurotransmission modulated by endogenous dopamine.
Summary:
- Local application of D1 receptor antagonist SCH 23390 caused short-latency inhibition and blocked long-latency inhibition.
- D2 receptor antagonist raclopride suppressed short-latency inhibition while unmasking long-latency inhibition.
- Findings suggest dopamine modulates GABA release in stria-pallidar terminals, influencing globus pallidus output.
Impact:
- Provides insights into the differential roles of dopamine receptor subtypes in basal ganglia function.
- Contributes to understanding the neurochemical basis of motor control and information processing in the brain.
- Offers potential targets for therapeutic interventions in neurological disorders involving dopamine dysregulation.